ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Lung Cancer - Staging

April 13, 2018
The authors demonstrate that mediastinoscopy at the time of either open or VATS lobectomy is independently associated with an increased risk of postoperative pulmonary complications (OR 1.46 and 1.53, respectively).
February 1, 2018
Decaluwé and colleagues prospectively tested the capacity of preoperative staging by video-assisted mediastinoscopy (VAM) or VAM-lymphadenectomy (VAM-LA) to detect hidden mediastinal lymph node involvement in patients with non-small cell lung cancer (NSCLC).
January 10, 2018
The authors explored the optimal extent of LN resection for T1aN0 carcinoid tumors undergoing lung resection using the National Cancer Data Base. Twenty-five percent of patients had no nodes evaluated.  Four percent of patients were upstaged based on node status.  Survival was similar comparing lobectomy to sublobar resection. 
August 2, 2017
This is an excellent summary of progress during the past year in all aspects of lung cancer, from prevention/detection through molecular therapies and future perspectives.  Each section is written by a handful of international experts. 
January 2, 2017
There is a rediscovered interest in use of a subxiphoid incision to perform lung surgery. This work follows a review of 105 lobectomies published in March 2016 in the Journal of Thoracic Disease from the same institution, Shanghai Pulmonary Hospital.
October 31, 2016
The authors examined the concordance of clinical and pathological staging using prospectively collected data from the Dutch Lung Surgery Audit, examining patients with clinical stage I disease.  Among 1,555 patients, the concordance of cTNM and pTNM was 60%.  22.6% of patients were upstaged after resection, .  The difference was more evident in patie
January 31, 2016
Whether open and VATS lobectomy for lung cancer result in similar nodal assessment is unclear.  The authors compared rates of nodal upstaging for nearly 17,000 patients in the National Cancer Database who underwent resection for T2N0M0 or lower stage NSCLC.  Upstaging was more common in patients undergoing open resection (12.8% vs 10.3%).
January 6, 2016
This long-awaited lung cancer staging update serves as the model for the AJCC 8 update that will be published in the near future.  The primary changes involve T status and an expansion of M status to include a single distant metastasis as T4c.  Stage IA is now subdivided into 3 stages, IIIC has been added, and stage IV has been expanded into IVA and
November 30, 2015
This is an interesting document adding the proposals for the next edition of lung cancer staging. the changes are going to be quite significant : 

Pages